Abstract
In response to the ongoing COVID-19 pandemics caused by SARS-CoV-2, governments are taking a wide range of non-pharmaceutical interventions (NPI). These measures include interventions as stringent as strict lockdown but also school closure, bars and restaurants closure, curfews and barrier gestures. Disentangling the effectiveness of each NPI is crucial to inform response to future outbreaks. To this end, we first develop a multi-level estimation of the French COVID-19 epidemic over a period of one year. We rely on a global extended Susceptible-Infectious-Recovered (SIR) mechanistic model of the infection including a dynamics over time for the transmission rate containing a Wiener process accounting for modeling error. Random effects are integrated by following an innovative population approach based on Kalman-type filter where the log-likelihood functional couples data across French regions. We then fit the estimated time-varying transmission rate using a regression model depending on NPI while accounting for the vaccination coverage, the apparition of variants of concern (VOC) and the seasonal weather conditions. We show that all NPI considered have a independent significant effect on the transmission rate. We additionally demonstrate a strong effect of weather condition, decreasing the transmission during the summer period, and also estimated an increased transmissibility of VOC.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work is supported in part by Inria Mission COVID19, project GESTEPID.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
n/a
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data used are available from the data.gouv.fr website of the French government.